CD68 and chondrosarcoma: Furthermore, in a validated cohort of 27 conventional and 49 dedifferentiated chondrosarcomas, a low expression of CD68+ TAMs was identified in approximately 39% of the patients, while its high expression was found in almost 61% [35].